Financial Avengers’s Vertex Pharmaceuticals VRTX Stock Holding History

Financial Avengers’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.8K	Hold	125	–	–	0.03%	56
2025 Q4	$56.7K	Hold	125	–	–	0.02%	60
2025 Q3	$49K	Sell	125 -15	-11%	-$6.27K	0.02%	64
2025 Q2	$62.3K	Hold	140	–	–	0.03%	54
2025 Q1	$67.9K	Sell	140 -10	-7%	-$4.66K	0.03%	55
2024 Q4	$60.4K	Hold	150	–	–	0.03%	60
2024 Q3	$69.8K	Hold	150	–	–	0.03%	58
2024 Q2	$70.3K	Hold	150	–	–	0.04%	51
2024 Q1	$63.1K	Hold	150	–	–	0.03%	53
2023 Q4	$61K	Hold	150	–	–	0.04%	52
2023 Q3	$52.2K	Hold	150	–	–	0.03%	53
2023 Q2	$52.8K	Sell	150 -50	-25%	-$16.8K	0.03%	53
2023 Q1	$63K	Hold	200	–	–	0.05%	48
2022 Q4	$57.8K	Hold	200	–	–	0.05%	48
2022 Q3	$58K	Sell	200 -50	-20%	-$14.4K	0.05%	45
2022 Q2	$70K	Sell	250 -100	-29%	-$26.8K	0.06%	44
2022 Q1	$91K	Hold	350	–	–	0.06%	44
2021 Q4	$77K	Sell	350 -50	-13%	-$9.72K	0.05%	50
2021 Q3	$73K	Hold	400	–	–	0.05%	51
2021 Q2	$81K	Sell	400 -361	-47%	-$75.5K	0.05%	48
2021 Q1	$164K	Sell	761 -4	-0.5%	-$879	0.12%	31
2020 Q4	$181K	Buy	+765	New	+$176K	0.15%	24

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Financial Avengers's VRTX Position: Q1 2026 in Review

Financial Avengers held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 125 shares worth $55.8K. The position accounts for 0.03% of the portfolio, ranked #56.

Financial Avengers first reported a position in VRTX in Q4 2020 and has held it in 22 quarters since. The position peaked at $181K in Q4 2020. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Financial Avengers held 125 shares of Vertex Pharmaceuticals worth $55.8K as of Q1 2026.
Financial Avengers left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
Vertex Pharmaceuticals made up 0.03% of Financial Avengers's portfolio in Q1 2026, its #56 holding.
Financial Avengers first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
Financial Avengers's Vertex Pharmaceuticals position peaked at $181K in Q4 2020.
1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Financial Avengers's 13F filing for Q1 2026, filed 19 May 2026.